{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:43:58Z","timestamp":1785336238357,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.preghy.2024.101177","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T17:36:57Z","timestamp":1733852217000},"page":"101177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4115-372X","authenticated-orcid":false,"given":"Anna C.M.","family":"Kluivers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugina I.","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanu","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-3585","authenticated-orcid":false,"given":"A.H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langeza","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.preghy.2024.101177_b0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bpobgyn.2011.04.002","article-title":"Pre-eclampsia in low and middle income countries","volume":"25","author":"Firoz","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"7","key":"10.1016\/j.preghy.2024.101177_b0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.preghy.2024.101177_b0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.23142","article-title":"Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model","volume":"58","author":"Saleh","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2024.101177_b0020","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.117.09913","article-title":"Angiogenic markers predict pregnancy complications and prolongation in preeclampsia: continuous versus cutoff values","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2024.101177_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejogrb.2016.02.013","article-title":"The sFlt-1\/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort","volume":"199","author":"Saleh","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.preghy.2024.101177_b0030","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine kinase-1\/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia","volume":"76","author":"Leanos-Miranda","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.preghy.2024.101177_b0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12884-020-2809-2","article-title":"Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study","volume":"20","author":"Huhn","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"13","key":"10.1016\/j.preghy.2024.101177_b0040","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/1471-0528.16323","article-title":"Glycosylated fibronectin point-of-care test for diagnosis of pre-eclampsia in a low-resource setting: a prospective Southeast Asian population study","volume":"127","author":"Nagalla","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2024.101177_b0045","doi-asserted-by":"crossref","unstructured":"J. Rasanen, M.J. Quinn, A. Laurie, E. Bean, C.T. Roberts, Jr., S.R. Nagalla, M.G. Gravett, Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia, Am J Obstet Gynecol 212(1) (2015) 82 e1-9.","DOI":"10.1016\/j.ajog.2014.07.052"},{"issue":"7","key":"10.1016\/j.preghy.2024.101177_b0050","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0002-9378(84)90468-X","article-title":"Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage","volume":"150","author":"Stubbs","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2024.101177_b0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-9378(89)90537-1","article-title":"Predictive value of increased plasma levels of fibronectin in gestational hypertension","volume":"161","author":"Ballegeer","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2024.101177_b0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0002-9378(92)91663-U","article-title":"The function of elevated plasma fibronectin in preeclampsia","volume":"166","author":"Brubaker","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2024.101177_b0065","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","article-title":"Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome","volume":"62","author":"Lyall","year":"2013","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.preghy.2024.101177_b0070","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/AOG.0b013e3182a0c88b","article-title":"Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes","volume":"122","author":"Rasanen","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2024.101177_b0075","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/uog.26303","article-title":"Screening for pre-eclampsia by maternal serum glycosylated fibronectin at 11-13 weeks' gestation","volume":"62","author":"Sokratous","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2024.101177_b0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/uog.27451","article-title":"Glycosylated fibronectin improves first-trimester prediction of pre-eclampsia","volume":"62","author":"Moungmaithong","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2024.101177_b0085","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/uog.27475","article-title":"Prediction using serum glycosylated fibronectin and angiogenic factors of superimposed pre-eclampsia in women with chronic hypertension","volume":"62","author":"Sokratous","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2024.101177_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/uog.26303","article-title":"Screening for pre-eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation","author":"Sokratous","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2024.101177_b0095","doi-asserted-by":"crossref","DOI":"10.1081\/PRG-100104165","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2024.101177_b0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"10.1016\/j.preghy.2024.101177_b0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.preghy.2024.101177_b0110","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200161","article-title":"Circulating angiogenic factor levels in hypertensive disorders of pregnancy","volume":"1","author":"Thadhani","year":"2022","journal-title":"NEJM Evid"},{"issue":"4","key":"10.1016\/j.preghy.2024.101177_b0115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/uog.26088","article-title":"Angiogenic imbalance in pre-eclampsia and fetal growth restriction: enhanced soluble fms-like tyrosine kinase-1 binding or diminished production of placental growth factor?","volume":"61","author":"Kluivers","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"20","key":"10.1016\/j.preghy.2024.101177_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10204792","article-title":"Glycation and glycosylation in cardiovascular remodeling: focus on advanced glycation end products and O-linked glycosylations as glucose-related pathogenetic factors and disease markers","volume":"10","author":"Dozio","year":"2021","journal-title":"J. Clin. Med."},{"issue":"16","key":"10.1016\/j.preghy.2024.101177_b0125","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1111\/jcmm.15552","article-title":"Glycation of fibronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-c-Src crosstalk","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.preghy.2024.101177_b0130","doi-asserted-by":"crossref","unstructured":"J.A. Otoo, T.S. Schlappi, REASSURED Multiplex Diagnostics: A Critical Review and Forecast, Biosensors (Basel) 12(2) (2022).","DOI":"10.3390\/bios12020124"},{"issue":"Suppl 1","key":"10.1016\/j.preghy.2024.101177_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13224-021-01566-y","article-title":"Glycosylated fibronectin point-of-care test for triage and surveillance of hypertension in pregnancy cases: a retrospective observational case control study","volume":"72","author":"Kesireddy","year":"2022","journal-title":"J. Obstet. Gynaecol. India"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778924002046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778924002046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:12:50Z","timestamp":1741299170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778924002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":27,"alternative-id":["S2210778924002046"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2024.101177","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2024.101177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101177"}}